Vivex Biomedical
Marietta, US · Founded 2012 · Delaware corporation
Founders & leadership
DH
Dr. H. Thomas TempleChief Medical Officer
BS
Barry SalzmanExecutive Chairman of Board of Directors
RJ
Ricardo J. NunezinGeneral Counsel and Corporate Secretary
TJ
Thomas J. GibsoninChief Financial Officer
HM
Holly MasonVice President of Marketing
TS
Tracy S. AndersonPresident and Chief Executive Officer
Board
RE
Richard E. PerlmanBoard director
JK
James K. PriceBoard director
JA
Jeffrey A. SmithBoard director
JM
J. Miguel Fernandez de CastroBoard director
TT
Timothy TaylorChairman of Board of Directors
JA
John A. McCallumBoard director
Reported raises · per SEC filings
Form D private placements$12.9M disclosed across 2 rounds · 2015–2017
▶$6.3MraisedMay 2017 · 38 investors · BiotechnologyRule 506(b)
▶$6.3MraisedMay 2017 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy Ganey, Ph.D.Executive Officer
- Holly MasonExecutive Officer
- John A. McCallumDirector
- Barry SalzmanDirector
- Dr. H Thomas TempleExecutive Officer
- James K. PriceDirector
- Tracy S. AndersonExecutive Officer, Director
- J. Miguel Fernandez de CastroDirector
- Timothy TaylorDirector
- U. Bertram Ellis, Jr.Director
- Stuart J KomenskiExecutive Officer
- Richard E. PerlmanDirector
- Offering amount
- $7M
- Amount sold
- $6.3M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6.6MraisedJan 2016 · 42 investors · BiotechnologyRule 506(b)
▶$6.6MraisedJan 2016 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. H. Thomas TempleExecutive Officer
- Richard E. PerlmanDirector
- James K. PriceDirector
- Barry SalzmanDirector
- Jeffrey A. SmithDirector
- J. Miguel Fernandez de CastroDirector
- Timothy TaylorDirector
- Ricardo J. NunezExecutive Officer
- John A. McCallumDirector
- Thomas J. GibsonExecutive Officer
- Holly MasonExecutive Officer
- Tracy S. AndersonExecutive Officer, Director
- U. Bertram Ellis, Jr.Director
- Timothy Ganey, Ph.D.Executive Officer
- Offering amount
- $10M
- Amount sold
- $6.6M
- Minimum investment
- $379
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Vivex Biomedical raised?
- Vivex Biomedical has disclosed $12.9M raised across 2 rounds.
- Where is Vivex Biomedical headquartered?
- Vivex Biomedical is headquartered in Marietta, US.